Targeting Bacillus anthracis toxicity with a genetically selected inhibitor of the PA/CMG2 protein-protein interaction. [electronic resource]
- Scientific reports 06 2017
- 3104 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2045-2322
10.1038/s41598-017-03253-3 doi
Animals Anti-Bacterial Agents--pharmacology Antigens, Bacterial--metabolism Bacillus anthracis--drug effects Bacterial Toxins--metabolism Cell Line, Tumor Drug Discovery--methods Protein Binding--drug effects Receptors, Peptide--metabolism